Newborn with severe epidermolysis bullosa: to treat or not to treat?

Research output: Contribution to journalJournal articleResearchpeer-review


Epidermolysis bullosa (EB) is an inherited skin disease with four main subtypes that cannot be distinguished clinically at birth. All subtypes may present with widespread life-threatening blisters and fragile skin, making treatment and handling of the newborn with EB challenging. The prognosis of EB depends on the subtype, and therefore maximum treatment is necessary until the final diagnosis is known. In this case, it took 2 weeks before a final diagnosis was reached. In the meantime, we had several ethical discussions on the treatment level. The most important issues were management of pain and nutrition. For immediate pain relief, intranasal fentanyl worked best and gabapentin was successfully used for chronic pain. The feeding difficulties were handled first by a nasogastric feeding tube. Later a normal feeding bottle proved to be adequate.

Original languageEnglish
Article number214727
JournalBMJ Case Reports
Number of pages4
Publication statusPublished - 26. Apr 2016


Dive into the research topics of 'Newborn with severe epidermolysis bullosa: to treat or not to treat?'. Together they form a unique fingerprint.

Cite this